UBS Group AG’s chairman warned against looming risks in the US insurance industry, citing weak and complex regulations amid ...

UBS Group AG’s chairman blasted his home market of Switzerland as losing its luster as a wealth management hub to Hong Kong and Singapore, while also warning against looming risks in the US insurance ...

While The Sopranos revolutionized television, these mob shows rival it in storytelling, performances, and criminal intrigue.

Lung06 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic NSCLC ...

On World Stroke Day, Minister Prataprao Jadhav urged integrative, preventive healthcare. Ayush systems, combining Ayurveda ...

Biotech and biopharma M&A activity has surged in recent weeks, sparking a strong sector rally and renewed optimism. Learn why ...

We wouldn’t send a soldier with severe PTSD back to war, so why are family courts sending children back to parents who have sexually abused them? Children who have been sexually abused by a parent or ...

Detailed results from bezuclastinib’s positive SUMMIT trial evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis planned for presentation at upcoming scientific conference this ...

Upadacitinib is now approved for IBD patients unsuitable for TNF blockers after one systemic therapy, broadening treatment options. Clinical trials show upadacitinib's efficacy in achieving remission ...

Crime and violence is all too real for families living on the Northern Cheyenne Reservation. Now, one Busby family is pushing to address those concerns. WWE star Hulk Hogan’s cause of death revealed ...

When obstetrician JoAnn Pinkerton spoke on a Food and Drug Administration panel recently, she didn't mince words. "Please stop harming women," she said. Pinkerton argues that the FDA's black box ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? While the study's findings have since been debunked (researchers later ...